How is trial registration affecting gjournals?
|
|
- Edmund Carroll
- 6 years ago
- Views:
Transcription
1 How is trial registration affecting gjournals? Dr Trish Groves Deputy editor, BMJ & Editor in chief, BMJ Open My competing interests Roles at BMJ contributing to, publicising, and leading implementation of the BMJ s policies on research influencing and making decisions on which research articles to send for external peer review and to accept; chairing weekly manuscript committee meeting at BMJ Open leading implementation of BMJ Open s policies and strategy overseeing decisions on peer review and manuscript decisions bmj.com and bmjopen.bmj.com carry advertisements for DIA meetings I have not received a fee or support for taking part in this conference 1
2 What I will cover ICMJE policy on trial registration What editors can do to promote trial registration and transparent reporting Evidence on the impact of trial registration What else editors could do Drug Information Association 3 Click to edit Master title style ICMJE policy: background Drug Information Association 4 2
3 Trial registration: story so far Drug Information Association years ago 3
4 ICMJE Sept 2004 mandated registration by Sept 2005 Why trial registration matters I Ottawa statement 2005 Ethical Respects investigator-participant covenant to contribute to public knowledge Provides global open access Reduces unnecessary duplication Assures accountability Enables monitoring of adherence to ethical principles and processes Scientific Increases reliability/availability of evidence for healthcare decisions Improves trial participation Increases collaboration Transparent design and methods Open review of protocols Identifies/prevents biased reporting Accelerates knowledge creation 4
5 Why trial registration matters II Distortion or loss of information about the true intervention can occur at each of four stages and the intervention may not reach practice without good reporting and trial fidelity Glasziou P et al. BMJ 2010;341:bmj.c3852 Drug Information Association 9 WHO platform & minimum dataset 2005 No mandated access to protocol in WHO dataset or at registries:
6 Declaration of Helsinki 2008 World Medical Association Declaration of Helsinki Ethical Principles for Medical Research Involving Human Subjects. Clause B19 Every clinical trial must be registered in a publicly accessible database before recruitment of the first subject. Drug Information Association 11 Click to edit Master title style Implementation of ICMJE policy Drug Information Association
7 What are the ICMJE rules? Trials that commenced after 1 July 2005 must have been registered prospectively, before participants enrolment, to be eligible for consideration at an ICMJE member journal * For trials of health services and behavioural interventions, relevant commencement date was 1 July 2008 Annals of Internal Medicine, British Medical Journal, Canadian Medical Association Journal, Chinese Medical Journal, Croatian Medical Journal, Journal of the American Medical Association, Nederlands Tijdschrift voor Geneeskunde (The Dutch Medical Journal), New England Journal of Medicine, New Zealand Medical Journal, The Lancet, The Medical Journal of Australia, Revista Médica de Chile, Tidsskrift for Den Norske Lægeforening (Journal of the Norwegian Medical Association), Ugeskrift for Laeger (Journal of the Danish Medical Association) Displaying registration details 7
8 But journals vary Drug Information Association 15 W h a t c a n / s h o u l d e d i t o r s d o? ask authors for registration details up front and if not ask authors for registration details up front and, if not supplied, ask again before external peer review ask for the full protocol and show it to reviewers check registry entries at initial internal peer review ask authors to explain deviations from protocol reject trials that are eligible but unregistered include, on publication, the trial registration details in each RCT s abstract publish protocols and/or post them with papers 8
9 Click to edit Master title style Impact of trial registration mandates Drug Information Association 17 Impact of ICMJE mandate in 2005 Zarin DA, Tse T, Ide NC. Trial registration at ClinicalTrials.gov between May and October N Engl J Med. 2005;353: Drug Information Association
10 Quality of trial registration in WHO ICTRP database Viergever RF Ghersi D, PLoS ONE 6(2): e % (n=731) of drug trials June 2008-June 09 >half registered after recruitment of first participant drug name/company serial no. usually there; other details missing of 3643 reported outcomes only 34.9% were specific measures with a meaningful time frame Reveiz L et al PLoS ONE 5(8): e12484 random sample (n=265) of actively recruiting trials in 2008 adequate reporting of risk of bias: sequence generation 5.7%, allocation concealment 1.4%, blinding 41%, primary outcomes 66% adequate reporting of other key elements: eligibility criteria 81%, secondary outcomes 46%, harms 5%, follow-up duration 62%, description of interventions 53%, sample size calculation 1% Drug Information Association 19 Outcome reporting in Clinical Trials.gov in trials of drugs in 5 classes industry 63%, government 14%, nonprofit or nonfederal 23% industry funded trials more often: were not published within 2 years of completion reported favourable outcomes when published Bourgeois F T et al. Ann Intern Med 2010;153: Drug Information Association
11 Registry and publications often vary RCTs in cardiology, rheumatology, gastroenterology in PubMed 2008 in the 10 general medical journals and specialty journals with the highest IFs. For each article trial registration was then checked Mathieu, S. et al. JAMA 2009;302: Drug Information Association 21 Update from ClinicalTrials.gov in 2010 As of September : 79,413 registered trials and 2178 records with results approx 330 new and 2000 revised registrations each week approx 30 new and 80 revised results each week from a sample of results records, 78 of 150 (52%) had associated publications within 2 years after posting of 100 recorded outcome measures, 61% lacked specificity of 700 results records 24% reported results for <90% participants Zarin DA, Tse T, Williams RJ, Califf RM, Ide NC. The ClinicalTrials.gov Results Database Update and Key Issues. N Engl J Med 2011;364: Drug Information Association
12 Click to edit Master title style Next steps in transparent reporting Drug Information Association 23 Publish or post protocols 12
13 Ensure transparent reporting of industry trials: BMJ policies Good Publication Practice 2 guidelines (gpp-guidelines.org) European Medical Writers Association guidelines on role of medical writers (emwa.org/ghostwriting-guidelines.html) MPIP authors toolkit ( Describe role and independence of study sponsor Provide with manuscript, on submission: trial protocol trial registration details CONSORT checklist, abstract, flowchart statements: competing interests, contributorship, ethics approval, funding, data sharing Promote good publication practice Drug Information Association
14 Is there more editors & publishers can do? Ask authors to: register studies and share results & raw data report new studies in context of what s known and what s added use reporting guidelines Develop and implement: more open access initiatives detailed policies on transparency focus on implementation research, comparative effectiveness policies to help mass media report science accurately ESF Forward Look Report May 2011: Implementation of Medical Research in Clinical Practice medical-sciences/implementation-of-medical-research-in-clinical-practice.html European Science Foundation & European Medical Research Councils May 2011 FL report: top 10 recommendations include: Promote rigorous reporting of all clinical studies Strengthen shared national and international open access databases on protocols, data, reports, systematic reviews and health technology assessment Drug Information Association
15 Systematic review registration Drug Information Association 29 Registries for data on medical devices Call for prospective registration of data on: outcomes & harms before regulatory approval postmarketing surveillance James S et al. BMJ 2011;342:doi: /bmj.d2826 Drug Information Association
16 Sharing research data: 2011 Signatories: Wellcome Trust, Hewlett Foundation, NIH, MRC, CIHR, Gates Foundation, INSERM, DFG, AHRQ among other major funders How can journals encourage data sharing? resources/datamanagement.xhtml Drug Information Association
17 Where to deposit data? Drug Information Association 33 Thanks Drug Information Association
How to write and publish a paper
How to write and publish a paper December 2018 Adrian Aldcroft, Editor in Chief, BMJ Open Writing research papers and using reporting guidelines Resources IMRaD Writing style Research to Publication rtop.bmj.com
More informationEverything You Wanted to Know About ClinicalTrials.gov*
Everything You Wanted to Know About * Deborah A. Zarin, MD Director, National Library of Medicine (*But Were Afraid to Ask) DISCLAIMER Views are mine and do not necessarily represent views of NIH or HHS
More informationAims and challenges of clinical trial data sharing
Aims and challenges of clinical trial data sharing Facilitating data access to non-industry funded research UCL and Yale meeting: 9 October 2015 London Dr Trish Groves Head of research,
More informationHow journals can help to make clinical trials honest, useful, and usable
How journals can help to make clinical trials honest, useful, and usable Special session on sharing IPD from clinical trials: ICTMC/SCT conference May 2017 Liverpool Dr Trish Groves tgroves@bmj.com twitter
More informationTowards Greater International Transparency of Clinical Trials
Karmela Krleza-Jeric,MD, M.Sc., D.Sc. CIHR - IRSC Towards Greater International Transparency of Clinical Trials Short Term Efforts for Long Term Benefits: CIHR trial policy 2010 1 Outline Prospective trial
More informationInformation for clinical researchers on transparency of clinical trial reporting
Information for clinical researchers on transparency of clinical trial reporting This document has been produced by leading UK healthcare organisations including the medical Royal Colleges and senior representatives
More informationThe Role and Importance of Clinical Trial Registries & Results Databases
The Role and Importance of Clinical Trial Registries & Results Databases Deborah A. Zarin, M.D. Director, ClinicalTrials.gov April 2016 http://clinicaltrials.gov 1 Outline Background Current Policies About
More informationJoint statement on public disclosure of results from clinical trials
Joint statement on public disclosure of results from clinical trials Signatories on 18 May 2017 European Commission for Horizon 2020 Societal Challenge Health Demographic Change and Wellbeing (joined on
More informationANZCTR Framework, challenges and immediate future
ANZCTR Framework, challenges and immediate future Professor Lisa Askie ANZCTR Manager Director, Systematic Reviews & Heath Technology Assessment The University of Sydney Page 1 Background and context The
More informationClinical Trial Registration: A Step towards Transparency and Accountability
ISSN (Print): 2456-7787 Society of Indian Physiotherapists Research Information Clinical Trial Registration: A Step towards Transparency and Accountability Sundar Kumar Veluswamy 1, Abraham Samuel Babu
More informationClinical Trials: Registration, Results Reporting, and Data Sharing
Clinical Trials: Registration, Results Reporting, and Data Sharing Jerry Sheehan Assistant Director for Policy Development National Library of Medicine National Institutes of Health OECD Expert Workshop
More informationUnpacking the evidence behind the AMWA EMWA ISMPP Joint Position Statement. Paul Farrow DPhil CMPP MedComms Networking Brunch Club 5 April 2017
Unpacking the evidence behind the AMWA EMWA ISMPP Joint Position Statement Paul Farrow DPhil CMPP MedComms Networking Brunch Club 5 April 2017 Paul Farrow DPhil CMPP Communications Director at Oxford PharmaGenesis
More informationResearch reporting and its integration into international policies on research for health in Latin America and the Caribbean (LAC)
Research reporting and its integration into international policies on research for health in Latin America and the Caribbean (LAC) EQUATOR Scientific Symposium 2012 Some slides shown at Ninth Regional
More informationThe CONSORT Statement II
L'Integrità della Ricerca Biomedica nell era dell'evidence-based Health Care Istituti Ortopedici Rizzoli Bologna, 23 novembre 2001 Consolidated olidated standards of Reporting Trial revised The CONSORT
More informationIN 2005, THE INTERNATIONAL COMmittee
ORIGINAL CONTRIBUTION Comparison of Registered and Published Primary Outcomes in Randomized Controlled Trials Sylvain Mathieu, MD Isabelle Boutron, MD, PhD David Moher, PhD Douglas G. Altman, DSc Philippe
More informationEuropean Stroke Journal: Declaration Guidelines for Authors
Table of Contents 1. Human Research and In Vitro Studies... 2 Required Declarations... 2 Example of a completed declarations section... 2 Example of text that should be used if any declaration is not relevant
More informationNot My Study Challenges of Clinical Trial Disclosure at an Academic Medical Center
Not My Study Challenges of Clinical Trial Disclosure at an Academic Medical Center Office of Research Compliance and Quality Assurance Yolanda P. Davis Sr. Research Compliance Officer Author: Yolanda P.
More informationGuiding Principles on the Sharing of Clinical Trial Data. DNDi POLICIES
Guiding Principles on the Sharing of Clinical Trial Data DNDi POLICIES May 2017 I. Preamble DNDi s vision is to improve the quality of life and health of people suffering from neglected tropical diseases
More informationScientific journal editor core competencies
Scientific journal editor core competencies My disclosures Founding editor-in-chief, Systematic Reviews On the editorial board of several biomedical journals BMC Medicine Advisory member International
More informationPRISMA-P: Preferred Reporting Items for Systematic Reviews and Meta- Analyses Protocols
PRISMA-P: Preferred Reporting Items for Systematic Reviews and Meta- Analyses Protocols Larissa Shamseer, MSc Reporting Guidelines Research Coordinator Knowledge Synthesis Group Overview What is a systematic
More informationBackground: ClincalTrials.gov and the database for Aggregate Analysis of ClincalTrials.gov (AACT)
Background: ClincalTrials.gov and the database for Aggregate Analysis of ClincalTrials.gov (AACT) Background! What is ClinicalTrials.gov?! ClinicalTrials.gov history! Key reporting requirements! Rationale
More informationIFPMA Response to World Health Organization International Clinical Trials Registry Platform (ICTRP) Consultation 30 September 2005
IFPMA Response to World Health Organization International Clinical Trials Registry Platform (ICTRP) Consultation 30 September 2005 Introduction In January 2005, the International Federation of Pharmaceutical
More informationGlaxoSmithKline (GSK) Response to World Health Organization International Clinical Trials Registry Platform (ICTRP) Consultation September 2005
GlaxoSmithKline (GSK) Response to World Health Organization International Clinical Trials Registry Platform (ICTRP) Consultation September 2005 Introduction GlaxoSmithKline (GSK) is committed to enhancing
More informationHow to avoid common problems when using ClinicalTrials.gov in research: 10 issues to consider
How to avoid common problems when using ClinicalTrials.gov in research: 10 issues to consider Tony Tse, 1 Kevin M Fain, 1 Deborah A Zarin 1 1 National Library of Medicine, National Institutes of Health,
More informationClinicalTrials.gov. Topics
ClinicalTrials.gov Federal Demonstration Partnership Meeting September 2018 Rebecca J. Williams, Pharm.D., MPH Acting Director, ClinicalTrials.gov National Library of Medicine https://clinicaltrials.gov
More informationClinicalTrials.gov REGISTRATION REQUIREMENTS
ClinicalTrials.gov REGISTRATION REQUIREMENTS Background: What is it? ClinicalTrials.gov is a public registry that provides easy access to information on clinical studies, both clinical trials and observational
More informationOverview of Good Publication Practice Guidelines, including GPP3: Why should medical writers care?
Overview of Good Publication Practice Guidelines, including GPP3: Why should medical writers care? Teresa Peña, PhD Head, Medical Publications Bristol-Myers Squibb ISMPP Board Chair & GPP3 Author San Antonio,
More informationTerry Sousa UMass Medical School PRS Administrator for Clinicaltrials.gov
Terry Sousa UMass Medical School PRS Administrator for Clinicaltrials.gov What is ClinicalTrials.gov? National registry of federally and privately supported research studies Why register and report results?
More informationIn its effort to develop worldwide
Policy Forum Open access, freely available online Clinical Trial Registration: The Differing Views of Industry, the WHO, and the Ottawa Group Karmela Krleža-Jeri In its effort to develop worldwide standards
More informationIncreasing value and reducing waste: Addressing inaccessible research
Increasing value and reducing waste: Addressing inaccessible research January 8, 2014 An-Wen Chan, MD DPhil Women s College Research Institute University of Toronto When I had to decide whether to have
More informationAuthorship and Algorithms: Assessing Authorship at Lilly. Jeffrey W. Clemens, Ph.D. Eli Lilly and Company
Authorship and Algorithms: Assessing Authorship at Lilly Jeffrey W. Clemens, Ph.D. Eli Lilly and Company 1 Disclosure I am an employee and stockholder of Eli Lilly and Company. Eli Lilly and Company has
More informationToward Greater Transparency and Rigor
Toward Greater Transparency and Rigor TRANSPARENCY: ClinicalTrials.gov registration and results reporting The Center for Clinical & Translational Science 205.934.7442 ccts@uab.edu www.uab.edu/ccts @cctsnetwork
More informationThe Yale Open Data Access (YODA) Project: Lessons Learned in Data Sharing
The Yale Open Data Access (YODA) Project: Lessons Learned in Data Sharing Grand Rounds: A Shared Forum of the NIH HCS Collaboratory and PCORnet June 30, 2017 Joseph S. Ross, MD, MHS Section of General
More informationProfessional medical writing support and the quality of randomised controlled trial reporting: a cross-sectional study
Professional medical writing support and the quality of randomised controlled trial reporting: a cross-sectional study William Gattrell, Sally Hopewell, Kate Young, Paul Farrow, Richard White, Elizabeth
More informationPOLICY AND PROCEDURE MANUAL
POLICY AND PROCEDURE MANUAL PBRC: POLICY NO. 378.00 ORIGIN DATE: 5/25/2016 IMPACTS: CLINICAL RESEARCH LAST REVISED: 1/1/2017 SUBJECT: SOURCE: PURPOSE PENNINGTON BIOMEDICAL CLINICALTRIALS.GOV POLICY INSTITUTIONAL
More informationPublication planning
Publication planning Liz Wager PhD Sideview liz@sideview.demon.co.uk Publication planning Publishing other people s data (keeping everybody happy) Understanding medical journals Keeping journal editors
More informationDisclosures. Objectives 02/06/2017
The 59 th annual meeting of the American Headache Society June 2017 Boston, Massachusetts Migraine Preventive Clinical Trial Data: Interpretation, Misinterpretation, and Integration into Future Study Designs
More informationSreeram V. Ramagopalan, Andrew P. Skingsley, Lahiru Handunnetthi, Michelle Klingel 2, Daniel Magnus 2, Julia Pakpoor 1, Ben Goldacre 2
SHORT RESEARCH ARTICLE Prevalence of primary outcome changes in clinical trials registered on ClinicalTrials.gov: a cross-sectional study [version 1; referees: 3 approved] Sreeram V. Ramagopalan, Andrew
More informationTCP Transl Clin Pharmacol
TCP 2018;26(4):172-176 https://doi.org/10.12793/tcp.2018.26.4.172 Trends of clinical trials from 2014 to 2016 in South Korea Ki Young Huh, Jun Gi Hwang and SeungHwan Lee* Department of Clinical Pharmacology
More informationAdvancing Research by Publishing Research Protocols and Negative Studies
Advancing Research by Publishing Research Protocols and Negative Studies Riaz Agha Balliol College, University of Oxford and Department of Plastic Surgery, Guy s and St. Thomas NHS Foundation Trust editor@journal-surgery.com
More informationTHANK YOU FOR JOINING ISMPP U TODAY!
THANK YOU FOR JOINING ISMPP U TODAY! The program will begin promptly at 11:00 am eastern January 31, 2013 2 ISMPP WOULD LIKE TO THANK.. the following Corporate Platinum Sponsors for their ongoing support
More informationARQUIVOS BRASILEIROS DE CARDIOLOGIA (BRAZILIAN ARCHIVES OF CARDIOLOGY) GUIDELINES FOR PUBLICATION
1 ARQUIVOS BRASILEIROS DE CARDIOLOGIA (BRAZILIAN ARCHIVES OF CARDIOLOGY) GUIDELINES FOR PUBLICATION 1. The Brazilian Archives of Cardiology (Arq Bras Cardiol) is a monthly publication of the Brazilian
More informationJournal Of Molecular Medicine Authorship Statement
Journal Of Molecular Medicine Authorship Statement American Journal of Respiratory and Critical Care Medicine Care Units An Official American Thoracic Society Statement: The Importance of Healthy Sleep.
More informationPolicy Appendix IV: DRCR.net Industry Collaboration Policies Version 6.0, August 2, 2017
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 DRCR.net is committed to: performing rigorous multi-center clinical
More informationHHS Public Access Author manuscript N Engl J Med. Author manuscript; available in PMC 2015 September 12.
Compliance with Results Reporting at ClinicalTrials.gov Monique L. Anderson, M.D, Karen Chiswell, Ph.D, Eric D. Peterson, M.D., M.P.H, Asba Tasneem, Ph.D, James Topping, M.S, and Robert M. Califf, M.D
More informationThe Proposed Rule for U.S. Clinical Trial Registration and Results Submission
The new england journal of medicine special report The Proposed Rule for U.S. Clinical Trial Registration and Results Submission Deborah A. Zarin, M.D., Tony Tse, Ph.D., and Jerry Sheehan, M.S. Broad access
More informationCompliance with Results Reporting at ClinicalTrials.gov
Special article Compliance with Results Reporting at ClinicalTrials.gov Monique L. Anderson, M.D., Karen Chiswell, Ph.D., Eric D. Peterson, M.D., M.P.H., Asba Tasneem, Ph.D., James Topping, M.S., and Robert
More informationPublication planning and guidelines
Publication planning and guidelines Elizabeth Wager PhD Sideview liz@sideview.demon.co.uk Publication planning Publishing other people s data (keeping everybody happy) Understanding medical journals Keeping
More informationClinicalTrials.gov Registration Guide
ClinicalTrials.gov Registration Guide The Food and Drug Administration Amendments Act (FDAAA), National Institutes of Health (NIH) and International Committee of Medical Journal Editors (ICMJE) require
More informationTrial Reporting in ClinicalTrials.gov The Final Rule
The new england journal of medicine Special Report Trial Reporting in ClinicalTrials.gov The Final Rule Deborah A. Zarin, M.D., Tony Tse, Ph.D., Rebecca J. Williams, Pharm.D., M.P.H., and Sarah Carr, B.A.
More informationClinicalTrials.gov Registration and Results Reporting: Updates and Recent Activity
Vol. 7, No. 2, February 2011 Can You Handle the Truth? ClinicalTrials.gov Registration and Results Reporting: Updates and Recent Activity By Matthew Lester and Barbara Godlew The Food and Drug Administration
More informationAdis Journals Overview
Adis Journals Overview Introduction Adis Rapid Publishing Service Life after publication AdisOnline.com The Adis publishing heritage The Adis Journals brand has evolved over 40 years to become synonymous
More informationSunshine on Europe: impact of recent EFPIA and EU guidelines on publication planners. Susan Scott, PhD, CMPP Director, Scott Pharma Solutions Ltd
Sunshine on Europe: impact of recent EFPIA and EU guidelines on publication planners Susan Scott, PhD, CMPP Director, Scott Pharma Solutions Ltd Disclaimer As an independent consultant, the views expressed
More informationNIH Policy on Dissemination of NIH- Funded Clinical Trial Information
NIH Policy on Dissemination of NIH- Funded Clinical Trial Information Valery Gordon, Ph.D., M.P.H. Senior Advisor for Human Subjects Protection Division of Clinical Innovation 2018 Spring CTSA Program
More informationPublication planning
Publication planning Liz Wager PhD Sideview liz@sideview.demon.co.uk Publication planning Publishing other people s data (keeping everybody happy) Understanding medical journals Keeping journal editors
More informationPan African Clinical Trials Registry (PACTR) Amber Abrams, Project Manager South African Cochrane Centre
Pan African Clinical Trials Registry (PACTR) Amber Abrams, Project Manager South African Cochrane Centre Acknowledgements The European and Developing Countries Clinical Trials Partnership (EDCTP) Trial
More informationThe Proposed Rule for U.S. Clinical Trial Registration and Results Submission
special report The Proposed Rule for U.S. Clinical Trial Registration and Results Submission Deborah A. Zarin, M.D., Tony Tse, Ph.D., and Jerry Sheehan, M.S. Broad access to information about clinical
More informationBecoming Aware of the Requirements Surrounding Clinical Trial Disclosure (ClinicalTrials.gov)
Becoming Aware of the Requirements Surrounding Clinical Trial Disclosure (ClinicalTrials.gov) Office of Research Compliance and Quality Assurance Yolanda P. Davis Sr. Research Compliance Officer Author:
More informationCompliance Department RESEARCH COMPLIANCE MEMORANDUM
Compliance Department RESEARCH COMPLIANCE MEMORANDUM To: UCD Health Chairs & Chief Administrator Officers From: Nirali Patel, Compliance Manager Kathy Olson, Research Compliance Analyst Re: Department
More informationwarwick.ac.uk/lib-publications
Original citation: Mistry, Pankai, Dunn, Janet A. and Marshall, A. (Andrea). (2017) A literature review of applied adaptive design methodology within the field of oncology in randomised controlled trials
More informationRDSOP16 Writing a GCP Compliant Protocol for Non-CTIMPs. Greater Manchester Mental Health NHS Foundation Trust
RDSOP16 Writing a GCP Compliant Protocol for Non-CTIMPs Greater Manchester Mental Health NHS Foundation Trust Title of Standard Operating Procedure: RDSOP16 Writing a GCP Compliant Protocol for Non-CTIMPs
More informationClinical Trials Registration: Your Obligations
Clinical Trials Registration: Your Obligations James Wells, PhD Office of Research Policy Graduate School Shari Zeldin, BS, CCRC UW Comprehensive Cancer Center University of Wisconsin-Madison Committee
More informationPolicy Appendix IV: DRCR.net Industry Collaboration Policies Version 5.0, February 2, 2009
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 DRCR.net is committed to: performing rigorous multi-center clinical
More informationDEFINING BEST PRACTICE FOR ADVERSE EVENT REPORTING WITH INDUSTRY-SPONSORED CLINICAL TRIAL MANUSCRIPTS
11TH ANNUAL MEETING OF ISMPP DEFINING BEST PRACTICE FOR ADVERSE EVENT REPORTING WITH INDUSTRY-SPONSORED CLINICAL TRIAL MANUSCRIPTS April 28, 2015 Hyatt Regency Crystal City Arlington, VA, USA 11TH ANNUAL
More informationOriginal Article A cross-sectional analysis of China-sponsored clinical trials registered with ClinicalTrials.gov
Int J Clin Exp Med 2016;9(6):10684-10694 www.ijcem.com /ISSN:1940-5901/IJCEM0020678 Original Article A cross-sectional analysis of China-sponsored clinical trials registered with ClinicalTrials.gov Yun
More informationWHO International Clinical Trials Registry Platform (ICTRP)
WHO International Clinical Trials Registry Platform (ICTRP) Dr. Patrick Unterlerchner Department of Research Policy & Cooperation Geneva, Switzerland Statement of New York Workgroup (Various Stakeholders,
More informationTHANK YOU FOR JOINING ISMPP U TODAY!
THANK YOU FOR JOINING ISMPP U TODAY! The program will begin promptly at 10:00 am EDT August 20, 2013 ISMPP WOULD LIKE TO THANK.. the following Corporate Platinum Sponsors for their ongoing support of the
More informationManuscript Submission Guidelines: Health Services Research and Managerial Epidemiology
Manuscript Submission Guidelines: Health Services Research and Managerial Epidemiology 1. Open Access 2. Peer Review Policy 3. Article Types 4. Publication Fees 5. Authorship 6. How to submit your manuscript
More informationJournal of Clinical Urology (JCU): Declaration Guidelines for Authors
Table of Contents 1. Case Report or Case Series... 2 Required Declarations... 2 Example of a completed declarations section:... 2 Example of text that should be used if any declaration is not relevant
More informationReview of the Registration in the Clinical Research Information Service
ORIGINAL ARTICLE Medical Informatics http://dx.doi.org/10.3346/jkms.2016.31.1.1 J Korean Med Sci 2016; 31: 1-8 Review of the Registration in the Clinical Research Information Service Eun-Kyoung Choi, Mi-Jung
More informationTHANK YOU FOR JOINING ISMPP U TODAY!
THANK YOU FOR JOINING ISMPP U TODAY! The program will begin promptly at 11:00 am EDT September 18, 2013 ISMPP WOULD LIKE TO THANK.. the following Corporate Platinum Sponsors for their ongoing support of
More informationClinical Research Management Webinar Series. ClinicalTrials.gov: Compliance for Academic Medical Centers and Research Sites.
Clinical Research Management Webinar Series ClinicalTrials.gov: Compliance for Academic Medical Centers and Research Sites February 23, 2011 1 Huron Consulting Group Inc. All rights reserved. Huron is
More informationYale University. Open Data Access Project
Open Data Access Project A Model for Dissemination and Independent Analysis of Clinical Trial Program Data Funded by a contract with Medtronic, Inc. Rationale A substantial number of clinical trials are
More informationARQUIVOS BRASILEIROS DE CARDIOLOGIA (BRAZILIAN ARCHIVES OF CARDIOLOGY) GUIDELINES FOR PUBLICATION
ARQUIVOS BRASILEIROS DE CARDIOLOGIA (BRAZILIAN ARCHIVES OF CARDIOLOGY) GUIDELINES FOR PUBLICATION 1. The Brazilian Archives of Cardiology (Arq Bras Cardiol) is a monthly publication of the Brazilian Society
More informationDevelopment and Implications of a Redacted Clinical Trial Protocol for Posting Online With the Published Manuscripts
Development and Implications of a Redacted Clinical Trial Protocol for Posting Online With the Published Manuscripts Namit Ghildyal, Yvette Ng, Craig Tendler, Chris H. Takimoto, Susan Glasser Janssen Research
More informationHouse of Commons Science and Technology Committee: Inquiry on clinical trials and disclosure of data
House of Commons Science and Technology Committee: Inquiry on clinical trials and disclosure of data Evidence submitted by the Medical Research Council, 26 February 2013 Introduction 1. The Medical Research
More informationApril 13, Background
Pfizer Inc 235 East 42nd Street New York, NY 10017-5755 Tel 212 733 4210 Fax 646 383 9249 Email: marc.wilenzick@pfizer.com April 13, 2009 http://www.regulations.gov Christine Ireland Committee management
More informationA systematic review of comparisons between protocols or registrations and full reports in primary biomedical research
Li et al. BMC Medical Research Methodology (2018) 18:9 DOI 10.1186/s12874-017-0465-7 RESEARCH ARTICLE Open Access A systematic review of comparisons between protocols or registrations and full reports
More informationHow many clinical trials are left unpublished?
How many clinical trials are left unpublished? We may never know the answer to this question. In some ways, maybe it doesn t matter. Even one clinical trial left unreported is unacceptable. There have
More informationEvaluation Tools for COMPUS
Evaluation Tools for COMPUS Background The Canadian Optimal Medication Prescribing and Utilization Service (COMPUS) identifies, evaluates, promotes and facilitates best practices in drug prescribing and
More informationPHS Human Subjects and Clinical Trials Information
PHS Human Subjects and Clinical Trials Information OMB Number: 925-1 Expiration Date: 3/31/22 Please complete the human subjects section of the Research & Related Other Project Information form prior to
More informationBayer Corporate Policy: Global Publications Deriving from Clinical Studies in Humans
Bayer Corporate Policy: Global Publications Deriving from Clinical Studies in Humans Overview The key aspects of this Global Publication Policy are commitment to publish; consistent application of authorship
More informationStrengthening ethics review systems
Strengthening ethics review systems Expert Conference on the Revision of the Declaration of Helsinki 5 7 December 2012 Cape Town, South Africa Dr Marie-Charlotte Bouësseau Ethics and Health Overview Normative
More informationResearch and publication ethics
Illustration inspired by the work of Chien Shiung Wu Research and publication ethics Stephanie Boughton, Research Integrity Group 24.05.2018 1 Housekeeping Rules To keep the technical process simple, we
More informationClinicalTrials.gov Registration Guide
ClinicalTrials.gov Registration Guide The Food and Drug Administration Amendments Act (FDAAA), National Institutes of Health (NIH) and International Committee of Medical Journal Editors (ICMJE) require
More informationBMJ Open. Publication rate for funded studies from a major UK health research funder: a cohort study
Publication rate for funded studies from a major UK health research funder: a cohort study Journal: BMJ Open Manuscript ID: bmjopen-0-00 Article Type: Research Date Submitted by the Author: 0-Jan-0 Complete
More informationGood publication practice for pharmaceutical companies
CURRENT MEDICAL RESEARCH AND OPINION VOL. 19, NO. 3, 2003, 149 154 0300-7995 doi:10.1185/030079903125001767 2003 LIBRAPHARM LIMITED Good publication practice for pharmaceutical companies Elizabeth Wager
More information1201 Maryland Avenue SW, Suite 900, Washington, DC ,
1201 Maryland Avenue SW, Suite 900, Washington, DC 20024 202-962-9200, www.bio.org June 6, 2008 Dockets Management Branch (HFA-305) Food and Drug Administration 5600 Fishers Lane, Rm. 1061 Rockville, MD
More informationNIH Policy Priorities for Clinical Research
NIH Policy Priorities for Clinical Research Kathy Hudson, Ph.D. Deputy Director for Science, Outreach, and Policy, NIH Federal Demonstration Partnership January 12, 2015 Topics Clinical Trial Results Reporting
More informationThe ClinicalTrials.gov Results Database Update and Key Issues
T h e n e w e ngl a nd j o u r na l o f m e dic i n e Special article The ClinicalTrials.gov Results Database Update and Key Issues Deborah A. Zarin, M.D., Tony Tse, Ph.D., Rebecca J. Williams, Pharm.D.,
More informationFergus Sweeney, European Medicines Agency
Fergus Sweeney, European Medicines Agency Disclaimer The views presented in this presentation/these slides are those of the author and should not be understood or quoted as being made on behalf of the
More informationTrial Reporting in ClinicalTrials.gov The Final Rule
Special Report Trial Reporting in ClinicalTrials.gov The Final Rule Deborah A. Zarin, M.D., Tony Tse, Ph.D., Rebecca J. Williams, Pharm.D., M.P.H., and Sarah Carr, B.A. Title VIII of the Food and Drug
More informationYale University. Open Data Access Project
Open Data Access Project A Model for Dissemination and Independent Analysis of Clinical Trial Program Data Funded by a contract with Medtronic, Inc. Session Objectives Why do we need to promote data sharing?
More informationNuts & Bolts of Clinical Trials, DSMBs, Event Committees, Core Labs and Data Standards
Nuts & Bolts of Clinical Trials, DSMBs, Event Committees, Core Labs and Data Standards Ron Waksman, MD Professor of Medicine, Georgetown University Associate Chief of Cardiology, Washington Hospital Center
More informationFood & Drug Administration Amendments Act of 2007
Food & Drug Administration Amendments Act of 2007 Implications for Public Planning Professionals and for Bio-Medical Publication Larry Hirsch, MD President, ISMPP January 17, 2008 Outline ISMPP What, Who,
More informationMulti-Regional Clinical Trials Center FDLI Webinar, November 10, 2015
Click to Edit Master Title Style Multi-Regional Clinical Trials Center FDLI Webinar, November 10, 2015 Building A Learning Community Among Key Stakeholders - 1 - Collaborating to Improve Multi-Regional
More informationTHE NEW ZEALAND MEDICAL JOURNAL
THE NEW ZEALAND MEDICAL JOURNAL Journal of the New Zealand Medical Association Clinical trials in New Zealand an update Vickie Currie, Andrew Jull Abstract Aims To describe clinical trial activity in New
More informationDownloaded from:
Tompson, AC; Petit-Zeman, S; Goldacre, B; Heneghan, CJ (2016) Getting our house in order: an audit of the registration and publication of clinical trials supported by the National Institute for Health
More informationPatricia Flatley Brennan, RN, PhD
The role of the National Library of Medicine in Reimagining the Research-Practice Relationship in the Post-Meaningful Use Era Patricia Flatley Brennan, RN, PhD Director National Library of Medicine With
More informationSHORT COMMUNICATION. Clinical Trial Registry: An essential requirement for physical therapy and health researchers in Pakistan
1079 SHORT COMMUNICATION Clinical Trial Registry: An essential requirement for physical therapy and health researchers in Pakistan Muhammad Osama, 1 Reem Javed Malik, 2 Muhammad Ehab Azim 3 Abstract Clinical
More information